Skip to main content
Log in

Invasionsmechanismen und Metastasierung des Urothelkarzinoms

Eine Herausforderung für die translationale Forschung

Invasion patterns and metastasis of urothelial carcinoma

A challenge for translational research

  • Übersichten
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Die Invasion von Tumorzellen tritt früh im Rahmen der lokalen Tumorprogression aggressiver Urothelkarzinome auf. Eine Mikrometastasierung in Lymph- oder Blutgefäße sowie das Vorhandensein von Lymphknotenmetastasen sind wichtige Prognosefaktoren für die krankheitsspezifische Mortalität. Der Metastasierungsprozess ist komplex und umfasst eine Kaskade multipler aufeinanderfolgender Schritte.

Für das Urothelkarzinom existieren wenige Daten aus präklinischen Studien über diese Mechanismen. Verschiedene Proteasen, Chemokine und Wachstumsfaktoren sind am Metastasierungsprozess beteiligt und pathophysiologische Veränderungen des Lymphgefäßsystems begünstigen die systemische Aussaat von Tumorzellen. Es besteht ein hoher Bedarf, neue Therapiemöglichkeiten zu entwickeln mit dem Ziel, in den Metastasierungsprozess einzugreifen.

Wir fassen Erkenntnisse über die Invasion und Metastasierung des Urothelkarzinoms zusammen und präsentieren ein innovatives experimentelles Modell, das funktionelle Aspekte berücksichtigt und dazu beitragen kann, die Mechanismen der Invasion besser zu verstehen sowie neue therapeutische Zielstrukturen zu identifizieren.

Abstract

Local invasion of cancer cells occurs early during the progression of urothelial carcinoma. Micrometastatic disease and the presence of nodal metastases are major causes of cancer-specific mortality following radical surgery. Only surrogate markers for aggressive and micrometastatic disease have been identified. The metastatic cascade is complex, including multiple steps from initial invasion to colonization and proliferation at distant sites.

The initial mechanisms of cancer cell dissemination in urothelial carcinoma are poorly understood. Various proteases, chemokines and growth factors are involved in this process and alterations of the lymphatic system may promote systemic spread. There is a high demand for therapeutic targeting of the metastatic process. Functional preclinical studies in representative models are therefore required to better elucidate the multiple steps of progression.

We review the current knowledge on factors associated with metastasis in urothelial carcinoma. Preclinical approaches to identify key player molecules for invasion and to develop new therapeutic strategies are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Bolenz C, Auer M, Strobel P et al (2012) The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value. Urol Oncol. doi:10.1016/j.urolonc.2012.02.012 (Epub ahead of print)

  2. Bolenz C, Fernandez MI, Trojan L et al (2009) Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int 103:1040–1046

    Article  PubMed  Google Scholar 

  3. Bolenz C, Gorzelanny C, Knauf D et al (2013) Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay. J Urol 189:1939–1944

    Article  PubMed  Google Scholar 

  4. Bolenz C, Herrmann E, Bastian PJ et al (2010) Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. BJU Int 106:493–499

    Article  PubMed  Google Scholar 

  5. Bolenz C, Lotan Y (2008) Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use. Nat Clin Pract Urol 5:676–685

    Article  PubMed  CAS  Google Scholar 

  6. Bolenz C, Shariat SF, Edwards T et al (2009) Expression of multiple biomarkers is associated with locally advanced urothelial carcinoma of the bladder in a prospective evaluation. J Urol 181:374

    Article  Google Scholar 

  7. Christofori G (2006) New signals from the invasive front. Nature 441:444–450

    Article  PubMed  CAS  Google Scholar 

  8. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174

    Article  PubMed  CAS  Google Scholar 

  9. Fernandez MI, Bolenz C, Trojan L et al (2008) Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol 53:571–578

    Article  PubMed  Google Scholar 

  10. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12:89–96

    Article  PubMed  Google Scholar 

  11. Goerge T, Barg A, Schnaeker EM et al (2006) Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. Cancer Res 66:7766–7774

    Article  PubMed  CAS  Google Scholar 

  12. Herrmann E, Eltze E, Kopke T et al (2007) New markers for pharmacological targeting in bladder cancer with lymph node metastasis. Aktuelle Urol 38:392–397

    Article  PubMed  CAS  Google Scholar 

  13. Jager T, Becker M, Eisenhardt A et al (2010) The prognostic value of cadherin switch in bladder cancer. Oncol Rep 23:1125–1132

    PubMed  Google Scholar 

  14. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  15. Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Ann Rev Pathol 3:367–397

    Article  CAS  Google Scholar 

  16. Kesler CT, Liao S, Munn LL et al (2013) Lymphatic vessels in health and disease. Wiley Interdiscip Rev Syst Biol Med 5:111–124

    Article  PubMed  CAS  Google Scholar 

  17. Knauf D, Gorzelanny C, Schneider SW et al (2012) Invasive growth of urothelial carcinoma of the bladder: functional role of matrix metalloproteinases-2, -7 and -9. Urologe 51:126

    Google Scholar 

  18. Lotan Y, Gupta A, Shariat SF et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533–6539

    Article  PubMed  Google Scholar 

  19. Ludwig T, Ossig R, Graessel S et al (2002) The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion. Am J Physiol Renal Physiol 283:319–327

    Google Scholar 

  20. Margulis V, Lotan Y, Montorsi F et al (2008) Predicting survival after radical cystectomy for bladder cancer. BJU Int 102:15–22

    Article  PubMed  Google Scholar 

  21. Martini T, Von Hardenberg J, Knauer A et al (2012) Expression der lymphspezifischen Marker VEGF-D, Flt-4, VEGF-C und CCR7 beim Urothelkarzinom der Harnblase. Assoziation mit histopathologischen Parametern und klinischem Verlauf. Urologe 51:80

    Article  Google Scholar 

  22. Misumi T, Yamamoto Y, Miyachika Y et al (2012) DNA copy number aberrations associated with lymphovascular invasion in upper urinary tract urothelial carcinoma. Cancer Genet 205:313–318

    Article  PubMed  CAS  Google Scholar 

  23. Nisato RE, Tille JC, Pepper MS (2003) Lymphangiogenesis and tumor metastasis. Thromb Haemost 90:591–597

    PubMed  CAS  Google Scholar 

  24. Retz MM, Sidhu SS, Blaveri E et al (2005) CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 114:182–189

    Article  PubMed  CAS  Google Scholar 

  25. Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414–2422 (discussion 2422)

    Article  PubMed  Google Scholar 

  26. Shariat SF, Youssef RF, Gupta A et al (2010) Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. J Urol 183:1744–1750

    Article  PubMed  Google Scholar 

  27. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666–675

    PubMed  CAS  Google Scholar 

  28. Szarvas T, Vom Dorp F, Ergun S et al (2011) Matrix metalloproteinases and their clinical relevance in urinary bladder cancer. Nat Rev Urol 8:241–254

    Article  PubMed  CAS  Google Scholar 

  29. Thiery JP, Acloque H, Huang RY et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890

    Article  PubMed  CAS  Google Scholar 

  30. Van Zijl F, Krupitza G, Mikulits W (2011) Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 728:23–34

    Article  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. C. Bolenz, T. Martini und M.S. Michel geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Bolenz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolenz, C., Martini, T. & Michel, M. Invasionsmechanismen und Metastasierung des Urothelkarzinoms. Urologe 52, 1242–1247 (2013). https://doi.org/10.1007/s00120-013-3309-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-013-3309-z

Schlüsselwörter

Keywords

Navigation